SUNCT Syndrome: Prolonged Attacks, Refractoriness and Response to Topiramate
Neurol 58:1307, Matharu,M.S.,et al, 2002
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Predictors of Functional Disability and Mortality After Status Epilepticus
Neurol 58:139-142, Claassen,J.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
Poststroke Seizures
Arch Neurol 59:195-202, Silverman,I.E.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Diagnostic Delay in Psychogenic Nonepileptic Seizures
Neurol 58:493-495, Reuber,M.,et al, 2002
Subacute Sclerosing Panencephalitis Clinical and Magnetic Resonance Imaging Evaluation of 36 Patients
J Child Neurol 17:25-29, Ozturk, A.,et al, 2002
Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002
Neurological Complications of Coeliac Disease
Postgrad Med J 78:393-398, Tengah, D.S.N.A.,et al, 2002
Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002
Crohns Disease
, Seiden, L. & Krumholz, A., 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002
HIV-Related Movement Disorders, Epidemiology, Pathogenesis and Management
CNS Drugs 16:663-668, Cardoso,F., 2002
Diffusion-Weighted Imaging of White Matter Abnormalities in Patients with Phenylketonuria
AJNR 22:1583-1586, Phillips,M.D.,et al, 2001
Effect of Food on Absorption of Dilantin Kapseals and Mylan Extended Phenytoin Sodium Capsules
Neurol 57 582-589,571, Wilder,B.J.,et al, 2001
Effect of Food on the Bioavailability of 100-mg Dilantin Kapseals
Neurol 57:698-700,571, Cook,J.,et al, 2001
A Comparison of Lorazepam,Diazepam,and Placebo for the Treqatment of Out-of-Hospital Status Epilepticus
NEJM 345:631-637,689, Alldredge,B.K.,et al, 2001
The Risk of Seizures After Receipt of Whole-Cell Pertussis or Measles,Mumps,and Rubella Vaccine
NEJM 345:656-661, Barlow,W.E.,et al, 2001
Painful Auras in Focal Epilepsy
Neurol 57:700-702, Nair,D.R.,et al, 2001
How Many Patients with Psychogenic Nonepileptic Seizures Also Have Epilepsy?
Neurol 57:915-917, Benbadis,S.R.,et al, 2001
Oxcarbazepine (Trileptal) as Monotherapy in Patients with Partial Seizures
Neurol 57:864-871, Sachdeo,R.,et al, 2001
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001
Spontaneous Occlusion of a Cerebral Arteriovenous Malformation:Angiography and MR Imaging Follow-up and Review of the Literature
AJNR 22:1556-1560, Krapf,H.,et al, 2001
Drop Attacks in Older Patients Secondary to an Otologic Cause
Neurol 57:1103-1106, Ishiyama,G.,et al, 2001
Mortality in Epilepsy in the First 11 to 14 Years After Diagnosis: Multivariate Analysis of a Long-Term, Prospective, Population-Based Cohort
Ann Neurol 49:336-344, Lhatoo,S.D.,et al, 2001
Epilepsy
NEJM 344:1145-1151, Browne,T.R. & Holmes,G.L., 2001
Transient MR Signal Changes in Patients with Generalized Tonic-Clonic Seizure or Status Eiplepticus: Periictal Diffusion-weighted Imaging
AJNR 22:1149-1160, Kim,J.,et al, 2001
Cerebral Amyloid Angiopathy Presenting as Nonhemorrhagic Diffuse Encephalopathy: Neuropathologic and Neuroradiologic Manifestations in One Case
AJNR 22:1072-1076, Caulo,M.,et al, 2001
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
Cerebral Sinovenous Thrombosis in Children
NEJM 345:417-423, DeVeber,G.,et al, 2001
Lamotrigine Reduces Painful Diabetic Neuropathy
Neurol 57:505-509, Eisenberg,E.,et al, 2001
Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001
Status Epilepticus After Stroke
Stroke 32:1169-1172, Velioglu,S.K.,et al, 2001
Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001
Differential Cognitive and Behavioral Effects of Carbamazepine and lamotrigine
Neurol 56:1177-1182, Meador, K.J.,et al, 2001
Transient Lesion in the Splenium of the corpus callosum: Three Further Cases in Epileptic Patients and a Pathophysiological Hypothesis
JNNP 70:459-463, Polster,T.,et al, 2001
The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001
Risk, Causes, and Prevention of Ischaemic Stroke in Elderly Patients with Symptomatic Internal-Carotid-Artery Stenosis
Lancet 357:1154-1160,1142, Alamowitch,S.,et al, 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001
Safety of Diastat When Given at Larger-than-recommended Doses for Acute Repetitive Seizures
Neurol 56:1112, Brown,L.,et al, 2001
Continuous EEG Monitoring and Midazolam Infusion for Refractory Nonconvulsive Status Epilepticus
Neurol 57:1036-1042, Claasen,J.,et al, 2001
Postpartum Blindness
Lancet 358:1338, Jurgensen,J.S.,et al, 2001
Serial EEG During Human Status Epilepticus
Neurol 57:1175-1183, Garzon,E.,et al, 2001
Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
Complete Genomic Screen in Parkinson Disease
JAMA 286:2239-2244, Scott,W.K.,et al, 2001